<?xml version="1.0" encoding="UTF-8"?>
<p>Among the many study associated with influenza infection, we did not find reports of adverse side effects of carrageenans at intranasal use. Moreover, in Europe, as already mentioned above, the use of the spray for intranasal administration as a preventive and therapeutic agent for influenza and ARIs is permitted. Apparently, attention should be paid to reports of negative phenomena associated with the use of carrageenans and to study this issue separately with respect to these infections.</p>
